Myomo (MYO) Gains from Sales and Divestitures (2017 - 2025)
Myomo (MYO) reported Gains from Sales and Divestitures of $52821.0 for Q3 2025, up 23.33% on a YoY basis from $42828.0 in Q3 2024, and down 91.8% quarter-over-quarter from $644149.0 in Q2 2025.
Myomo (MYO) Gains from Sales and Divestitures (2017 - 2025) Analysis & Trends
Myomo has reported Gains from Sales and Divestitures for 9 years, with the latest figure at $52821.0 in Q3 2025.
- For the quarter ending Q3 2025, Gains from Sales and Divestitures rose 23.33% year-over-year to $52821.0; the trailing twelve-month figure through Sep 2025 stood at $52821.0 (up 23.33% YoY), and the FY2024 full-year result was $1.0 million, up 195.87% from the prior year.
- Gains from Sales and Divestitures for Q3 2025 stood at $52821.0, down from $644149.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $1.0 million in Q4 2024, with the low at $10.0 in Q1 2021.
- Historically, Gains from Sales and Divestitures has averaged $209609.4 across 5 years, with a median of $133270.0 in 2022.
- Annual changes were most pronounced in 2021 — Gains from Sales and Divestitures slumped 99.85% — and 2022, when it surged 971480.0%.
- Myomo's Gains from Sales and Divestitures stood at $153357.0 in 2021, then dropped by 10.45% to $137332.0 in 2022, then surged by 147.14% to $339409.0 in 2023, then jumped by 195.87% to $1.0 million in 2024, then plunged by 94.74% to $52821.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $52821.0 (Q3 2025), $644149.0 (Q2 2025), and $59031.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 52,821.00 |
| Sep 30, 2025 | 52,821.00 |
| Jun 30, 2025 | 644,149.00 |
| Jun 30, 2025 | 644,149.00 |
| Mar 31, 2025 | 59,031.00 |
| Mar 31, 2025 | 59,031.00 |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 42,828.00 |
| Sep 30, 2024 | 42,828.00 |
| Jun 30, 2024 | 636,801.00 |
| Jun 30, 2024 | 636,801.00 |
| Mar 31, 2024 | 300,544.00 |
| Mar 31, 2024 | 300,544.00 |
| Dec 31, 2023 | 339,409.00 |
| Dec 31, 2023 | 339,409.00 |
| Sep 30, 2023 | 199,163.00 |
| Sep 30, 2023 | 199,163.00 |
| Jun 30, 2023 | 169,499.00 |
| Jun 30, 2023 | 169,499.00 |